Display options
Cite
Barraclough D, Brook A, Brooks P, et al. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. J Rheumatol Suppl. 1982;8:197-200
Barraclough, D., Brook, A., Brooks, P., Boyden, K., Thomas, D., & Tymms, K. (1982). A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. The Journal of rheumatology. Supplement, 8197-200.
Barraclough, D, et al. "A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report." The Journal of rheumatology. Supplement vol. 8 (1982): 197-200.
Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. J Rheumatol Suppl. 1982 Jul-Aug;8:197-200. PMID: 6813485.
Copy Download .nbib Format: NLM
Share it on

J Rheumatol Suppl. 1982 Jul-Aug;8:197-200.

A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.

The Journal of rheumatology. Supplement

D Barraclough, A Brook, P Brooks, K Boyden, D Thomas, K Tymms

PMID: 6813485

Abstract

We compared auranofin (AF) in a single blind multi-centre study with gold sodium thiomalate and D-penicillamine in the treatment of rheumatoid arthritis. Adult patients with disease duration 6-60 months without previous treatment with gold salts with persistent active disease, were included. Thirty-nine patients, 13 in each treatment group, have so far been entered. Cumulative toxicity data and some results of efficacy assessments in those completing 9 months of treatment are presented. AF is very well tolerated, judgment concerning efficacy must await the end of the trial.

Substances

MeSH terms

Publication Types